Despite its potential appeal to patent owners don’t expect a litigation stampede to Waco

Appointment of experienced patent litigator to local bench and Austin's growing reputation as a tech hub must be weighed against defendant-friendly rules

Despite its potential appeal to patent owners don’t expect a litigation stampede to Waco
22 Jan 2019

Bridgestone's TomTom acquisition shows that data is the new gold rush

The $1 billion deal emphasises that for IP professionals a detailed understanding of data-related issues is set to become essential

22 Jan 2019

Blockchain startup’s new tack reveals much about what IP managers need most

Operem is still working toward building a blockchain platform for patent trading, but its first product reflects demand for tools that enable open innovation efforts and trade secret protection

Featured

22 Jan
2019

Drilling down: the high cost of ignoring patent type

While portfolio size is often used as an indicator of value, it is crucial to remember that patent type can be just as significant as the number of rights – especially when it comes to FRAND negotiations Read more

21 Jan
2019

Remember - it is Qualcomm's licensing practices that are currently on trial, not its technology

Amassing more than $7 billion in annual royalties, as the San Diego business did at its peak a few years ago, cannot simply be the product of sharp elbowed monetisation tactics Read more

21 Jan
2019

It's time to prepare for the IP monetisation revolution

The rise of disruptive new technology means that everything you thought you knew about making money from IP is set to change Read more

News

View all
20 Jan 2019

Bristol Myers’ Celgene gamble, Apple’s IPR attack on Qualcomm, 2018’s US patent litigation stats, key CRISPR facts, plus much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one Read more

18 Jan 2019

The clock is ticking as US government shutdown threatens to cause major pharma patent disruption

Services at the FDA could “grind to a halt” in a matter weeks if the budget deadlock between President Trump and Democrats continues. Major disruption at the USPTO and in the courts may also be on the cards. Read more

16 Jan 2019

New collaboration between leading IP brands set to boost global patent transactions

IAM Market teams up with Richardson Oliver Insights to deliver new tranche of assets to its IP buying, selling, licensing and tech transfer platform being offered by top brokers Read more

16 Jan 2019

Five things you must know about CRISPR

An insider’s guide to how it has revolutionised the life sciences patent landscape - and will continue to do so Read more

Analysis

View all
21 Jan 2019

New Indian patent office rules set to speed examinations

Draft changes would entitle women inventors and small businesses to expedited patent examination, but some see a backdoor for big business to take advantage too Read more

19 Jan 2019

Google makes big wearables play to show sector still has appeal for Silicon Valley elite

$40 million deal with Fossil involves acquisition of IP relating to smartwatch technology and will also see transfer of an R&D team Read more

18 Jan 2019

Downward trend in US patent litigation continues; Big Tech gets busier at the PTAB

Lawsuit filings and inter partes review petitions both fell in 2018, but operating companies’ share of the action was on the rise  Read more

18 Jan 2019

US prosecutors may resurrect trade secrets charges against Huawei

The Department of Justice is considering charging Huawei with stealing trade secrets related to a phone testing robot developed by T-Mobile . But in a 2014 civil trial on the same issues, the US carrier’s punches failed to land Read more

Events

View all
28 Jan
2019
Latest

Pharma & Biotech IP 2019

With disruptive political and legislative change on the horizon at home and abroad, it has never been more important for European biopharma patent professionals to have a crystal-clear understanding of the changes shaping IP protection and value creation. This event will provide cutting-edge legal and strategic insights to help practitioners safeguard and exploit their crucial life sciences assets.

27-28 March
2019
Latest

IPBC Europe 2019

In the era of the fourth industrial revolution (4IR), European companies are faced with a number of exciting opportunities – but also significant IP challenges. Designed by and for European IP owners, the programme for IPBC Europe 2019 will explore how IP managers inside the continent’s businesses can devise and build sustainable value creation programmes in the rapidly changing world.

16-18 June
2019
Latest

IPBC Global 2019

The leading gathering of global IP decision makers and thought-leaders returns to Boston! As the fourth industrial revolution gathers pace, IPBC Global’s 2019 programme explores the key IP issues this new era of change and innovation presents for corporate leaders, policy makers, investors, the legal profession and third-party service providers.

Insights

30 Nov 2018

IP market news highlights

Some of the major stories carried on the IAM platform in October and November. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

27 Sep 2018

A Brexit IP issue with serious political consequences

The UPC and EU trademarks will not inflame any Brexit passions among those outside the IP bubble, but geographical indications are a different matter altogether Read more

27 Sep 2018

IP market news highlights

Some of the major stories carried on the www.IAM-media.com platform in August and September Read more

Analysis

Latest analysis reports from IAM.

Thought leadership

IAM offers an extensive range of special reports.

Why subscribe?

Our unique and timely intelligence service informs commercial trademark decision making in boardrooms globally by translating trademark law into business sense.